Lasmiditan Catalog No.:M10338-10 5)6)15-17-30(16-14-28)20-23(33)36-26(7

5)6)15-17-30(16-14-28)20-23(33)36-26(7

INCB3284 dimesylate

Molecular Weight: 832

Effect of c-Met inhibitor SU11274 on human colon cancer cell growth

in mice induces a rapid Akt phosphorylation readily detectable in lung lysates

Lasmiditan Catalog No.:M10338-10 5)6)15-17-30(16-14-28)20-23(33)36-26(7Lasmiditan, also known as COL 144 and LY573144, is a novel, centrally acting, highly selective 5 HT(1F) receptor agonist (K1=2. 21 M) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof of concept migraine study. Lasmiditan showed efficacy in its primary endpoint, with a 2 hour placebo subtracted headache response of 28. 8%, though with frequent reports of dizziness, paresthesias, and vertigo.